2-Arylpropionic CXC Chemokine Receptor 1 (CXCR1) Ligands as Novel Noncompetitive CXCL8 Inhibitors-Reference-Cited by-同舟云学术

2-Arylpropionic CXC Chemokine Receptor 1 (CXCR1) Ligands as Novel Noncompetitive CXCL8 Inhibitors

Published:2005-05-27 Issue:13 Volume:48 Page:4312-4331
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Allegretti Marcello¹,Bertini Riccardo¹,Cesta Maria Candida¹,Bizzarri Cinzia¹,Di Bitondo Rosa¹,Di Cioccio Vito¹,Galliera Emanuela¹,Berdini Valerio¹,Topai Alessandra¹,Zampella Giuseppe¹,Russo Vincenzo¹,Di Bello Nicoletta¹,Nano Giuseppe¹,Nicolini Luca¹,Locati Massimo¹,Fantucci Piercarlo¹,Florio Saverio¹,Colotta Francesco¹

Affiliation:

1. Dompé Research and Development, Dompé S.p.A., via Campo di Pile, 67100, L'Aquila, Italy, Centro IDET, Institute of General Pathology, University of Milan, 20133 Milan, Italy, Department of Biotechnologies and Biosciences, University of MilanBicocca, 20122, Milan, Italy, and C.I.N.M.P.I.S. PharmacyChemistry Department, University of Bari, 70125 Bari, Italy

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm049082i

Reference59 articles.

1. The chemokine system: redundancy for robust outputs

2. Chemokines

3. Chemokine receptors

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palladium-catalyzed dehydrogenation of α-cyclohexene-substituted nitriles to α-aryl nitriles;Chemical Communications;2024

2. Neutrophils as potential therapeutic targets for breast cancer;Pharmacological Research;2023-12

3. Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment;Frontiers in Oncology;2023-04-11

4. Exploration of Pyrido[3,4-d]pyrimidines as Antagonists of the Human Chemokine Receptor CXCR2;Molecules;2023-02-23

5. Dynamic kinetic asymmetric arylation and alkenylation of ketones;Science;2023-02-17